Search

Objective: Hereditary hypophosphatemias (HH) are rare monogenic conditions characterized by decreased renal tubular phosphate reabsorption. The aim of this study was to explore the prevalence, genotypes, phenotypic spectrum, treatment response, and complications of treatment in the Norwegian population of children with HH., Design: Retrospective national cohort study., Methods: Sanger sequencing and multiplex ligand-dependent probe amplification analysis of PHEX and Sanger sequencing of FGF23, DMP1, ENPP1KL, and FAM20C were performed to assess genotype in patients with HH with or without rickets in all pediatric hospital departments across Norway. Patients with hypercalcuria were screened for SLC34A3 mutations. In one family, exome sequencing was performed. Information from the patients' medical records was collected for the evaluation of phenotype., Results: Twety-eight patients with HH (18 females and ten males) from 19 different families were identified. X-linked dominant hypophosphatemic rickets (XLHR) was confirmed in 21 children from 13 families. The total number of inhabitants in Norway aged 18 or below by 1st January 2010 was 1,109,156, giving an XLHR prevalence of ∼1 in 60,000 Norwegian children. FAM20C mutations were found in two brothers and SLC34A3 mutations in one patient. In XLHR, growth was compromised in spite of treatment with oral phosphate and active vitamin D compounds, with males tending to be more affected than females. Nephrocalcinosis tended to be slightly more common in patients starting treatment before 1 year of age, and was associated with higher average treatment doses of phosphate. However, none of these differences reached statistical significance., Conclusions: We present the first national cohort of HH in children. The prevalence of XLHR seems to be lower in Norwegian children than reported earlier., (© 2016 The authors.)

Unlabelled: Vitamin D-dependent rickets type 1 (VDDR1) was diagnosed in a 15-month-old girl with well-controlled phenylketonuria (PKU). The patient was homozygous for the PAH mutation L249F. The PAH and CYP27B1 genes are both located on the long arm of chromosome 12 and could possibly have been inherited from a common ancestor. The parents were not aware of any ancestral relationship and the patient was compound heterozygous for two different CYP27B1 mutations (R389H and S416X). Her mutations were shown to originate from each of her four grandparents. In Norway, the co-occurrence of PKU and VDDR1 is expected to occur by chance one to two times per billion births., Conclusion: The extremely rare co-occurrence of VDDR1 and PKU requires careful genetic work-up and close attention to family information, but the combined treatment of the two metabolic disorders may not create special problems.